Kishnani
Amit Kishnani, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20130332257 | SHARING PRIVATE DEVICES FOR CONTENT RENDERING - An apparatus and method for accessing a voluntary pool of devices for remote content rendering is disclosed herein. A brokering device receives a request from a content provider device to render content on a device, the request including the content to be rendered and specifying a type of the device on which the content is to be rendered. The brokering device also receives availability conditions from a test device. The brokering device selects the test device in accordance with the request and the availability conditions. The test device is instructed to fulfill the content rendering request. | 12-12-2013 |
20140006225 | AUTOMATIC DEVICE INVENTORY MANAGEMENT FOR DIFFERENT TYPES OF DEVICES | 01-02-2014 |
20140040361 | SYNCHRONIZED CONTENT DISPLAY ACROSS A PLURALITY OF DEVICES - An apparatus and method for synchronized content display across a plurality of devices are disclosed herein. Content specified at a first device is deployed to the rest of the plurality of devices that are of diverse device types to each other. The first device instructs the other devices to render the content at each of the respective devices according to the respective device's content viewer and configuration. The first device also instructs the other devices to achieve a certain setting or state pertaining to true rendering of the content depending on the type of content to be rendered. | 02-06-2014 |
20140040490 | AUTOMATIC CONNECTION OF COMPUTING DEVICES - In one embodiment, a method of connecting to a client computing device is provided. The method is performed at a computing device, and in this method a connection is made to the client computing device. An inventory of the client computing device is then accessed. This inventory is stored in a storage device accessible by way of a computer network. Here, the storage device is separate from the client computing device and the computing device. A connection failure between the computing device and the client computing device is detected and thereafter, the inventory from the storage device is retrieved by way of the computer network. A reconnection to the client computing device can then be made based on the retrieved inventory. | 02-06-2014 |
20140136944 | REAL TIME WEB DEVELOPMENT TESTING AND REPORTING SYSTEM - Elements of the geometry of the image of a webpage as rendered on at least one target browser are compared with elements of a baseline geometry of the webpage to determine the differences between elements of the baseline geometry of the webpage and elements of the respective geometries of the image of the webpage as rendered on the at least one target browser. The elements of the image may be determined by a software tool for determining elements of a document geometry, such as a DOM geometry service. Code such as JavaScript may be injected into the webpage for use in determining the elements of the geometry of the image of the webpage. A list of issues that web developers face may be generated and the above differences between respective elements may allow arriving at a solution for at least some of the issues in order to provide testing of webpage information in real time. | 05-15-2014 |
Amit C. Kishnani, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20140304679 | SOFTWARE DEVELOPMENT TOOL THAT PROVIDES CONTEXT-BASED DATA SCHEMA CODE HINTING - A software application development tool provides context-based data schema code hinting. Code “regions” are defined in the code for an application that is under development. One or more data sources that are referenced by a code region may be defined. The development tool detects when a designer is attempting to reference a data schema, such as by detecting that the designer has input a specified trigger, within a region of the code, and in response, the development tool provides code hints for the data schema for corresponding data source(s) that is/are referenced in the corresponding code region in which the designer is working. Thus, rather than providing data schema code hinting for all data sources referenced by the application, targeted code hinting is employed by presenting data schema code hints for only the data source(s) that are referenced by a defined code region in which the designer is working. | 10-09-2014 |
Narendra Kishnani, East Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20140162942 | INHIBITION OF CYP3A DRUG METABOLISM - The present invention provides methods, pharmaceutical compositions, medicaments, and pharmaceutical kits that employ the use of boceprevir as a CYP3A4/5 inhibitor to improve the pharmacokinetics of therapeutic compounds metabolized by cytochrome P450 3A4/5 (CYP3A4/5) enzymes. | 06-12-2014 |
Priya S. Kishnani, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20130052189 | METHOD OF TREATING PATIENTS UNDERGOING PROTEIN REPLACEMENT THERAPY, GENE REPLACEMENT THERAPY, OR OTHER THERAPEUTIC MODALITIES - The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapy involving the administration of a proteinaceous therapeutic agent as well gene replacement therapy with non-viral or viral vectors, or other therapeutic modality or modalities, used alone or in combination, which involve the administration of exogenous substances for potential therapeutic benefit, including, but not limited to DNA vaccines, siRNA, splice-site switching oligomers (SSOs) as well as RNA-based nanoparticles (RNPs) and nanovaccines. The invention further relates to compounds and compositions suitable for use in such methods. | 02-28-2013 |
20150037329 | METHOD OF REDUCING TITERS OF ANTIBODIES SPECIFIC FOR A THERAPEUTIC AGENT - The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapy involving the administration of a proteinaceous therapeutic agent as well gene replacement therapy with non-viral or viral vectors, or other therapeutic modality or modalities, used alone or in combination, which involve the administration of exogenous substances for potential therapeutic benefit, including, but not limited to DNA vaccines, siRNA, splice-site switching oligomers (SSOs) as well as RNA-based nanoparticles (RNPs) and nanovaccines. The invention further relates to compounds and compositions suitable for use in such methods. | 02-05-2015 |